ATH 33.3% 0.4¢ alterity therapeutics limited

imagine extension trial proceeds, page-5

  1. 357 Posts.
    lightbulb Created with Sketch. 113
    so 33 out of 40 continued, very good.

    But remember, of the 7 who didn't continue, 4 had completed IMAGINE before the extension trial was announced, some up to five months before.

    So of those who finished IMAGINE after the extension trial was available, only 3 didn't continue. Very, very good.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.